Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Nalmefene, sold under the brand name Revex among others, is a medication that is used in the treatment of opioid overdose and alcohol dependence. Nalmefene belongs to the class of opioid antagonists and can be taken by mouth, administered by injection, or delivered through nasal administration.
Applications & Research
Explore the main themes, entities and connections around Nalmefene. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
alcohol opioid treatment mor dependence naltrexone medication overdose kor brain hours administration mouth antagonist receptor intravenous also name affinity people
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Nalmefene | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Nalmefene | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Nalmefene | ATC code | N07BB05 (WHO) | 1.00 | infobox |
| Nalmefene | Bioavailability | 40–50% (orally) | 1.00 | infobox |
| Nalmefene | CAS Number | 55096-26-9 Y | 1.00 | infobox |
| Nalmefene | CAS Number | as HCl: 58895-64-0 | 1.00 | infobox |
| Nalmefene | ChEBI | CHEBI:7457 | 1.00 | infobox |
| Nalmefene | ChEMBL | ChEMBL982 Y | 1.00 | infobox |
| Nalmefene | ChEMBL | as HCl: ChEMBL1201152 | 1.00 | infobox |
| Nalmefene | ChemSpider | 4447642 Y | 1.00 | infobox |
| Nalmefene | ChemSpider | as HCl: 4534959 | 1.00 | infobox |
| Nalmefene | CompTox Dashboard (EPA) | DTXSID8023347 | 1.00 | infobox |
| Nalmefene | Drug class | Opioid antagonist; κ-Opioid receptor agonist | 1.00 | infobox |
| Nalmefene | DrugBank | DB06230 | 1.00 | infobox |
| Nalmefene | DrugBank | as HCl: DBSALT001446 | 1.00 | infobox |
| Nalmefene | ECHA InfoCard | 100.164.948 | 1.00 | infobox |
| Nalmefene | Elimination half-life | 10.8 ± 5.2 hours | 1.00 | infobox |
| Nalmefene | Excretion | Kidney | 1.00 | infobox |
| Nalmefene | Formula | C21H25NO3 | 1.00 | infobox |
| Nalmefene | IUPHAR/BPS | 1628 | 1.00 | infobox |
| Nalmefene | KEGG | D05111 | 1.00 | infobox |
| Nalmefene | KEGG | as HCl: D02104 | 1.00 | infobox |
| Nalmefene | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Nalmefene | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Nalmefene | Legal status | US: ℞-only | 1.00 | infobox |
| Nalmefene | Legal status | EU: Rx-only | 1.00 | infobox |
| Nalmefene | License data | US DailyMed: Nalmefene | 1.00 | infobox |
| Nalmefene | MedlinePlus | a605043 | 1.00 | infobox |
| Nalmefene | Metabolism | Liver | 1.00 | infobox |
| Nalmefene | Molar mass | 339.435 g·mol−1 | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.